Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability.A Comparison Between Vildagliptin and Gliclazide MR
Phase of Trial: Phase IV
Latest Information Update: 13 Feb 2016
At a glance
- Drugs Vildagliptin (Primary) ; Gliclazide
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms BONEGLYC
- 10 Jun 2017 Biomarkers information updated
- 09 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2013 Planned end date changed from 1 Apr 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov record.